474 studies found for:    HIV OR AIDS | Open Studies | NIH
Show Display Options
Rank Status Study
21 Recruiting Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition: HIV Infection
Intervention: Drug: Pegylated Interferon Alpha 2b (PEGINTRON)
22 Recruiting VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...
Conditions: HIV-1 Infection;   Neutralizing Antibody;   Monoclonal Antibody;   Viral Load;   HIV Antibodies
Intervention: Biological: VRC-HIVMAB060-00-AB
23 Recruiting Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
Conditions: Acquired Immune Deficiency Syndrome Virus;   Acquired Immunodeficiency Syndrome Virus;   AIDS Virus;   Human Immunodeficiency Virus;   Human Immunodeficiency Viruses
Intervention:
24 Recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma
Conditions: HIV Infection;   HIV-associated Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Drug: dacarbazine;   Drug: brentuximab vedotin;   Other: pharmacological study;   Other: laboratory biomarker analysis
25 Not yet recruiting Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Drug: GSK1265744 Tablets;   Drug: Injectable GSK1265744;   Drug: Placebo for GSK1265744 Tablets;   Drug: Injectable Placebo for GSK1265744
26 Not yet recruiting Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: BMS-936559;   Drug: Placebo for BMS-936559
27 Recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
28 Recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
29 Recruiting Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
30 Recruiting Clinical Outcomes in Persons With HIV Acquired Early in Life
Conditions: HIV;   Childhood;   Natural History;   Cardiac;   ART
Intervention:
31 Unknown  Effects of HIV and Hepatitis C Virus on the Brain
Conditions: HIV Infections;   Hepatitis C
Intervention:
32 Unknown  HIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
Intervention: Drug: ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz
33 Recruiting Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Conditions: HIV;   Kaposi's Sarcoma;   Lymphomas;   Multicentric Castleman's Disease;   Primary Effusion Lymphoma
Intervention:
34 Unknown  Resistance to HIV Infection
Condition: HIV Infections
Intervention:
35 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo
36 Recruiting Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Condition: Human Immunodeficiency Virus
Intervention:
37 Not yet recruiting Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: ABT-450/r/ABT-267;   Drug: ABT-333;   Drug: Ribavirin
38 Recruiting Safety of and Immune Response to Dolutegravir (GSK1349572) in HIV-1 Infected Infants, Children, and Adolescents
Condition: HIV Infections
Interventions: Drug: Dolutegravir (DTG) tablet formulation;   Drug: DTG oral pediatric granules taken as suspension or granules
39 Recruiting Evaluating Safety and Effectiveness of Low-Dose Methotrexate at Reducing Inflammation in HIV-Infected Adults Taking Antiretroviral Medications
Condition: HIV Infections
Interventions: Drug: Methotrexate (MTX);   Drug: Placebo;   Dietary Supplement: Folic acid
40 Recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years